Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Aeglea BioTherapeutics Investor Presentation Deck slide image

Aeglea BioTherapeutics Investor Presentation Deck

SPY002 is a potential best-in-class TL1A mAb Complete TL1A blockade Monomer and trimer Picomolar trimer potency Half-life extension Q8-12W dosing Source: Company materials SPYRE SPY002 MK-7240 RVT-3101 TEV-48574 24
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube